Gene Delivery Using Chemical Methods - Challenges in Delivery of Therapeutic Genomics and Proteomics - page 200

[308] Kihara F, Arima H, Tsutsumi T, Hirayama F, Uekama K. In vitro and in vivo gene trans-
fer by an optimized alpha-cyclodextrin conjugate with polyamidoamine dendrimer.
Bioconjugate Chem 2003;14:342-50.
[309] Choi JS, Nam K, Park JY, Kim JB, Lee JK, Park JS. Enhanced transfection efficiency
of PAMAM dendrimer by surface modification with L-arginine. J Controllled Release
2004;99:445-56.
[310] Wood KC, Azarin SM, Arap W, Pasqualini R, Langer R, Hammond PT. Tumor-targeted
gene delivery using molecularly engineered hybrid polymers functionalized with a
tumor-homing peptide. Bioconjugate Chem 2008;19:403-5.
[311] Buhleier E, Wehner W, Vögtle F. Cascade and nonskid-chain-like synthesis of molecu-
lar cavity topologies. Synthesis 1978;2:155-8.
[312] de Brandender-van den Berg EM, Meijer EW. Poly (propylene imine) dendrimers:
large-scale synthesis by heterogeneously catalyzed hydrogenations. Angew Chem Int
Ed Engl 1993;32:1308-11.
[313] Worner C, Mulhaupt R. Polynitrile and polyamine-functional poly(trimethylene mine)
dendrimers. Angew Chem Int Ed Engl 1993;32:1306.
[314] Scherrenberg R, Coussens B, van Vliet P, Edouard G, Brackman J, de Brabander E.
The molecular characteristics of poly (propyleneimine) dendrimers as studied with
small-angle neutron scattering, viscosimetry, and molecular dynamics. Macromolecules
1998;31:456-61.
[315] Kabanov VA, Zezin AB, Rogacheva VB, Gulyaeva ZG, Zansochova MF, Joosten JGH,
et al. Interaction of astramol polypropylenimine dendrimers with linear polyanions.
Macromolecules 1999;32:1904-9.
[316] Kabanov VA, Sergeyev VG, Pyshkina OA, Zinchenko AA, Zezin AB, Joosten JGH,
et al. Interpolyelectrolyte complexes formed by DNA and astramol poly(propylene
imine) dendrimers. Macromolecules 2000;33:9587-93.
[317] Gebhart CL, Kabanov AV. Evaluation of polyplexes as gene transfer agents. J Control
Release 2001;73:401-16.
[318] Zinselmeyer BH, Mackay SP, Schatzlein AG, Uchegbu IF. The lower-generation
polypropylenimine dendrimers are effective gene-transfer agents. Pharm Res 2002;
19:960-7.
[319] Dufes C, Keith WN, Bilsland A, Proutski I, Uchegbu IF, Schaetzlein AG. Synthetic
anticancer gene medicine exploits intrinsic antitumor activity of cationic vector to cure
established tumors. Cancer Res 2005;65:8079-84.
[320] Schatzlein AG, Zinselmeyer BH, Elouzi A, Dufes C, Chim YTA, Roberts CJ, et al.
Preferential liver gene expression with polypropylenimine dendrimers. J Control
Release 2005;101:247-58.
[321] Omidi Y, Hollins AJ, Drayton RM, Akhtar S. Polypropylenimine dendrimer-induced
gene expression changes: the effect of complexation with DNA, dendrimer generation
and cell type. J Drug Target 2005;13:431-43.
[322] Kim TI, Baek JU, Bai CZ, Park JS. Arginine-conjugated polypropylenimine dendrimer
as a non-toxic and efficient gene delivery carrier. Biomaterials 2007;28:2061-7.
[323] Denkewalter RG, Kolc J, Lukasavage WJ. Macromolecular highly branched homoge-
nous compound based on lysine units. US Patent 4,289,872; 1981.
[324] Aharoni SM, Crosby CR III, Walsh EK. Size and solution properties of globular tert bu-
tyloxycarbonyl-poly(a,e-L-lysine). Macromolecules 1982;15:1093-8.
[325] Choi JS, Joo D, Kim CH, Kim K, Park JS. Synthesis of a barbell-like triblock copo-
lymer, poly(L-lysine) dendrimer-block-poly(ethylene glycol)-block-poly(L-lysine) den-
drimer and its self-assembly with plasmid DNA. J Am Chem Soc 2000;122:474-80.